NCT05429398 2022-06-23A Study of Linperlisib Combination With Camrelizumab in Patients With Solid TumorShanghai YingLi Pharmaceutical Co. Ltd.Phase 1 Unknown118 enrolled
NCT04282278 2021-12-10Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid TumorHebei Medical University Fourth HospitalPhase 2 Unknown180 enrolled